Fibromyalgia Drug Pipeline Landscape Report 2024 Featuring Tonix Pharmaceuticals, Virios Therapeutics, Tryp Therapeutics, Axsome Therapeutics, Scilex, Silo Pharma,& UCB Biopharma
June 17, 2024 07:33 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Fibromyalgia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This Report provides comprehensive insights...
Fibromyalgia Treatment Market Size to Worth USD 4.13 Billion by 2032
June 05, 2024 11:10 ET
|
Precedence Research
Ottawa, June 05, 2024 (GLOBE NEWSWIRE) -- The global fibromyalgia treatment market size is estimated to grow from USD 2.77 billion in 2023 to approximately USD 4.13 billion by 2032. This growth is...
US Fibromyalgia Market and Competitive Landscape 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecasts, Drugs Sales
May 31, 2021 07:53 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "US Fibromyalgia Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Fibromyalgia Market and...
Fibromyalgia Treatment Market to Reach USD 1,414.4 Million by 2027; Increasing Investments in R&D for Pain Management Therapies to Bolster Growth, states Fortune Business Insights™
March 09, 2021 06:00 ET
|
Fortune Business Insights
Pune, India, March 09, 2021 (GLOBE NEWSWIRE) -- The global fibromyalgia treatment market size is expected to reach USD 1,414.4 million by 2027, exhibiting a CAGR of 9.2% during the forecast period....